FDA data Registry peer set 2 peers

Alternatives to risedronate

2 same-class SPL records vs risedronate - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Actonel

Bisphosphonate Prescription 2 alternatives found

About risedronate

Risedronate sodium delayed-release tablets help treat osteoporosis after menopause. It helps to make your bones stronger and less likely to break.

Used for: This medicine treats osteoporosis in women after menopause. Osteoporosis makes bones weak and more likely to break. Risedronate can lower the chance of breaks in the spine and other bones.

2 Bisphosphonate peers (wide set)

Compare risedronate vs alendronate side-by-side →

risedronate vs alendronate & ibandronate · FAERS reaction fields

FAERS top-reaction field "Pain" shows the widest count spread between risedronate and alendronate, ibandronate in this extract (9,914-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect risedronate alendronateibandronate
Arthralgia 3,730 11,003 243
Pain 3,613 13,527 161
Nausea 2,991 7,565 219
Fatigue 2,911 12,775 190
Dyspnoea 2,802 7,447 132
Vomiting 2,735 - 138
Diarrhoea 2,685 - 230
Pneumonia 2,434 - -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

risedronate peer mix vs class inventory

Peer mix

0 OTC and 2 Rx SPL records in this peer set (2 total). Class inventory for Bisphosphonate: 3 drugs.

Frequently Asked Questions

What same-class SPL records sit beside risedronate?
This registry lists 2 Bisphosphonate medication records beside risedronate, including alendronate, ibandronate. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Bisphosphonate peer set (2 records)

risedronate (Actonel) sits in a wide Bisphosphonate peer set (2 of 2 class peers shown). Labeled indication field for risedronate: This medicine treats osteoporosis in women after menopause.

Top FAERS reaction fields for risedronate total 28,645 reports across 10 reactions, set beside alendronate, ibandronate. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full risedronate profile →

Field note for risedronate: see also the generic vs brand label guide when reading Actonel SPL strings.